A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
The blood-brain barrier (BBB) can be temporarily disrupted with microbubble-mediated focused ultrasound (FUS). Here, we describe a step-by-step protocol for high-throughput BBB opening in vivo using a modular FUS system accessible for non-ultrasound experts.
The blood-brain barrier (BBB) has been a major hurdle for the treatment of various brain diseases. Endothelial cells, connected by tight junctions, form a physiological barrier preventing large molecules (>500 Da) from entering the brain tissue. Microbubble-mediated focused ultrasound (FUS) can be used to induce a transient local BBB opening, allowing larger drugs to enter the brain parenchyma.
In addition to large-scale clinical devices for clinical translation, preclinical research for therapy response assessment of drug candidates requires dedicated small animal ultrasound setups for targeted BBB opening. Preferably, these systems allow high-throughput workflows with both high-spatial precision as well as integrated cavitation monitoring, while still being cost effective in both initial investment and running costs.
Here, we present a bioluminescence and X-ray guided stereotactic small animal FUS system that is based on commercially available components and fulfills the aforementioned requirements. A particular emphasis has been placed on a high degree of automation facilitating the challenges typically encountered in high-volume preclinical drug evaluation studies. Examples of these challenges are the need for standardization in order to ensure data reproducibility, reduce intra-group variability, reduce sample size and thus comply with ethical requirements and decrease unnecessary workload. The proposed BBB system has been validated in the scope of BBB opening facilitated drug delivery trials on patient-derived xenograft models of glioblastoma multiforme and diffuse midline glioma.
The blood-brain barrier (BBB) is a major obstacle for drug delivery into the brain parenchyma. Most therapeutic drugs that have been developed do not cross the BBB due to their physicochemical parameters (e.g., lipophilicity, molecular weight, hydrogen bond acceptors and donors) or are not retained due to their affinity for efflux transporters in the brain1,2. The small group of drugs that can cross the BBB are typically small lipophilic molecules, which are only effective in a limited number of brain diseases1,2. As a consequence, for the majority of ....
All in vivo experiments were approved by the Dutch ethical committee (license permit number AVD114002017841) and the Animal Welfare Body of the Vrije Universiteit Amsterdam, the Netherlands. The investigators were trained in the basics of the FUS system in order to minimize the discomfort of the animals.
1. Focused ultrasound system
NOTE: The described setup is an inhouse built BBB disruption system based on commercially available components and includes a 3D-printed .......
The described FUS system (Figure 1 and Figure 2) and the associated workflow have been used in over a 100 animals and produced reproducible data on both healthy and tumor bearing mice. Based on the recorded cavitation and the spectral density at the harmonics at the peak moment of the microbubble bolus injection, the spectral power of each frequency can be calculated using the Fourier analysis as explained in step 4 of the Protocol. Based on the acoustic protoco.......
In this study, we developed a cost-effective image guided based FUS system for transient BBB disruption for increased drug delivery into the brain parenchyma. The system was largely built with commercially available components and in conjunction with X-ray and BLI. The modularity of the proposed design allows the use of several imaging modalities for planning and assessment in high-throughput workflows. The system can be combined with more comprehensive high-resolution 3D imaging modalities, for example high-resolution M.......
This project was funded by the KWF-STW (Drug Delivery by Sonoporation in Childhood Diffuse Intrinsic Pontine Glioma and High-grade Glioma). We thank Ilya Skachkov and Charles Mougenot for their input in the development of the system.
....Name | Company | Catalog Number | Comments |
1 mL luer-lock syringe | Becton Dickinson | 309628 | Plastipak |
19 G needle | Terumo Agani | 8AN1938R1 | |
23 G needle | Terumo Agani | 8AN2316R1 | |
3M Transpore surgical tape | Science applied to life | 7000032707 | or similar |
Arbitrary waveform generator | Siglent | n.a. | SDG1025, 25 MHz, 125 Msa/s |
Automated stereotact | in-house built | n.a. | Stereotact with all elements were in-house built |
Bruker In-Vivo Xtreme | Bruker | n.a. | Includes software |
Buffered NaCl solution | B. Braun Melsungen AG | 220/12257974/110 | |
Buprenorfine hydrochloride | Indivior UK limitd | n.a. | 0.324 mg |
Cage enrichment: paper-pulp smart home | Bio services | n.a. | |
Carbon filter | Bickford | NC0111395 | Omnicon f/air |
Ceramic spoon | n.a | n.a. | |
Cotton swabs | n.a. | n.a. | |
D-luciferin, potassium salt | Gold Biotechnology | LUCK-1 | |
Ethanol | VUmc pharmacy | n.a. | 70% |
Evans Blue | Sigma Aldrich | E2129 | |
Fresenius NaCl 0.9% | Fresenius Kabi | n.a. | NaCl 0.9 %, 1000 mL |
Histoacryl | Braun Surgical | n.a. | Histoacryl 0.5 mL |
Hydrophone | Precision Acoustics | n.a. | |
Insulin syringe | Becton Dickinson | 324825/324826 | 0.5 mL and 0.3 mL |
Isoflurane | TEVA Pharmachemie BV | 8711218013196 | 250 mL |
Ketamine | Alfasan | n.a. | 10 %, 10 mL |
Mouse food: Teklad global 18% protein rodent diet | Envigo | 2918-11416M | |
Neoflon catheter | Becton Dickinson | 391349 | 26 GA 0.6 x 19 mm |
Oscilloscope | Keysight technologies | n.a. | InfiniiVision DSOX024A |
Plastic tubes | Greiner bio-one | 210261 | 50 mL |
Power amplifier | Electronics & Innovation Ltd | 210L | Model 210L |
Preamplifier DC Coupler | Precision Acoustics | n.. | Serial number: DCPS94 |
Scissors | Sigma Aldrich | S3146-1EA | or similar |
Sedazine | AST Farma | n.a. | 2% |
SonoVue microbubbles | Bracco | n.a. | 8 µl/ml |
Sterile water | Fresenius Kabi | n.a. | 1000 mL |
Syringe | n.a. | n.a. | various syringes can be used |
Temgesic | Indivior UK limitd | n.a. | 0.3 mg/ml |
Transducer | Precision Acoustics | n.a. | 1 MHz |
Tweezers | Sigma Aldrich | F4142-1EA | or similar |
Ultrasound gel | Parker Laboratories Inc. | 01-02 | Aquasonic 100 |
Vidisic gel | Bausch + Lomb | n.a. | 10 g |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved